EDAP TMS SA : EDAP TMS SA to Announce Third Quarter 2018 Financial Results on Wednesday, November 14

LYON, France, November 6, 2018 - EDAP TMS SA EDAP, the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended September 30, 2018, after the close of the financial markets on Wednesday, November 14, 2018.

An accompanying conference call will be conducted by Philippe Chauveau, Chairman of the Board, Marc Oczachowski, Chief Executive Officer; and François Dietsch, Chief Financial Officer, to review the results. The call will be held at 8:30 AM ET, on Thursday, November 15, 2018. Please refer to the information below for conference call dial-in information and webcast registration.

Conference Call & Webcast

Thursday November 15th @ 8:30am Eastern Time

Domestic:                                800-289-0438

International                            323-794-2423

Passcode:                                9039159

Webcast:                                 http://public.viavid.com/index.php?id=131508

Replays, Available through November 29, 2018:

Domestic:                                844-512-2921

International:                           412-317-6671

Replay PIN:                            9039159

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market for almost 40 years, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for urology using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion. As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems. For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com.

CONTACTS:

Blandine Confort

Investor Relations / Legal Affairs

EDAP TMS SA

+33 4 72 15 31 50

bconfort@edap-tms.com

Investor Contact

Jeremy Feffer

LifeSci Advisors, LLC

212-915-2568

jeremy@lifesciadvisors.com